Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates

Molecular Medicine

Volumn 4, Issue 12, 1998, Pages 772-782

  Tsuboi, Takafumi ^a   Kaslow, David C ^b   Gozar, Mary Margaret G ^b   Tachibana, Mayumi ^a   Cao, Ya Ming ^a,c   Torii, Motomi ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE; MEMBRANE PROTEIN; PROTOZOAL DNA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGENICITY; ARTICLE; GENE ISOLATION; GENETIC POLYMORPHISM; IMMUNOGENICITY; MALARIA; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; VACCINE PRODUCTION;

EID: 0032427485     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401770     Document Type: Article

References (35)

1. 1. WHO. (1997) World Malaria Situation in 1994. Weekly Epidemiological Record, WHO, Geneva.
2. 2. Kaslow DC. (1992) Transmission-blocking immunity against malaria and other vector-borne diseases. Curr. Opin. Immunol. 5: 557-565.
3. 3. Kaslow DC. (1996) Transmission-blocking vaccines. In: Hoffman SL (ed). Malaria Vaccine Development: A Multi-Immune Response Approach. ASM Press, Washington, DC, pp. 181-227.
4. 4. Kaslow DC, Quakyi IA, Syin C, et al. (1988) A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature 335: 74-76.
5. 5. Duffy PE, Kaslow DC. (1997) A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines. Infect. Immun. 65: 1109-1113.
6. 6. Kaslow DC, Syin C, McCutchan TF, Miller LH. (1989) Comparison of the primary structure of the 25 kDa ookinete surface antigens of Plasmodium falciparum and Plasmodium gallinaceum reveal six conserved regions. Mol. Biochem. Parasitol. 33: 283-287.
7. 7. Duffy PE, Pimenta P, Kaslow DC. (1993) Pgs28 belongs to a family of epidermal growth factor-like antigens that are targets of malaria transmission-blocking antibodies. J. Exp. Med. 177: 505-510.
8. 8. Tsuboi T, Kaslow DC, Cao Y-M, Shiwaku K, Torii M. (1997) Comparison of Plasmodium yoelii ookinete surface antigens vvith human and avian malaria parasite homologues reveals two highly conserved regions. Mol. Biochem. Parasitol. 87: 107-111.
9. 9. Tsuboi T, Cao Y-M, Hitsumoto Y, Yanagi T, Kanbara H, Torií M. (1997) Two antigens on zygotes and ookinetes of Plasmodium yoelii and Plasmodium berghei that are distinct targets of transmission-blocking immunity. Infect. Immun. 65: 2260-2264.
10. 10. Tsuboi T, Cao Y-M, Kaslow DC, Shiwaku K, Torii M. (1997) Primary structure of a novel ookinete surface protein from Plasmodium berghei. Mol. Biochem. Parasitol. 85: 131-134.
11. 11. Paton MG, Barker GC, Matsuoka H, et al. (1993) Structure and expression of a post-transcriptionally regulated malaria gene encoding a surface protein from the sexual stages of Plasmodium berghei. Mol. Biochem. Parasitol. 59: 263-276.
12. 12. Murphy GS, Basri H, Purnomo, et al. (1993) Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 341: 96-100.
13. 13. Golenda CF, Li J, Rosenberg R. (1997) Continuous in vitro propagation of the malaria parasite Plasmodium vivax. Proc. Natl. Acad. Sci. U.S.A. 94: 6786-6791.
14. 14. Premawansa S, Peiris JSM, Perera KLRL, Ariyaratne G, Carter R, Mendis KN. (1990) Target antigens of transmission blocking immunity of Plasmodium vivax malaria. Characterization and polymorphism in natural parasite isolates. J. Immunol. 144: 4376-4383.
15. 15. Snewin VA, Premawansa S, Kapilananda GMG, et al. (1995) Transmission blocking immunity in Plasmodium vivax malaria: antibodies raised against a peptide block parasite development in the mosquito vector. J. Exp. Med. 181: 357-362.
16. 16. Fried M, Gwadz RW, Kaslow DC. (1994) Identification of two cysteine-rich, lipophilic proteins on the surface of Plasmodium knowlesi ookinetes: Pks20 and Pks24. Exp. Parasitol. 78: 326-330.
17. 17. Baker GC, Rodriguez MH, Sinden RE. (1994) Attempted isolation of the gene encoding the 21 kD Plasmodium berghei ookinete transmission-blocking antigen from Plasmodium yoelii and Plasmodium vivax. Mem. Inst. Oswaldo Cruz 89 (Suppl. II): 37-41.
18. 18. Waters AP, Higgins DG, McCutchan TF. (1991) Plasmodium falciparum appears to have arisen as a result of lateral transfer between avian and human hosts. Proc. Natl. Acad. Sci. U.S.A. 88: 3140-3144.
19. 19. Campbell CC, Collins WE, Chin W, Roberts JM, Broderson JR. (1983) Studies of the Sal I strain of Plasmodium vivax in the squirrel monkey (Saimiri sciureus). J Parasitol. 69: 598-601.
20. 20. Devon RS, Porteous DJ, Brookes AJ. (1995) Splinkerettes-improved vectorettes for greater efficiency in PCR walking. Nucl. Adds Res. 23: 1644-1645.
21. 21. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS. (1991) 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucl. Acids Res. 19: 4008.
22. 22. Kaslow DC, Quakyi IA, Keister DB. (1989) Minimal variation in a vaccine candidate from the sexual stage of Plasmodium falciparum. Mol. Biochem. Parasitol. 32: 101-104.
23. 23. Ya-Ping S, Alpers MP, Povoa MM, Lal AA. (1992) Single amino acid variation in the ookinete vaccine antigen from field isolates of Plasmodium falciparum. Mol. Biochem. Parasitol. 50: 179-180.
24. 24. Hafalla JCR, Santiago MLO, Pasay MCJ, et al. (1997) Minimal variation in the Pfs28 ookinete antigen from Philippine field isolates of Plasmodium falciparum. Mol. Biochem. Parasitol. 87: 97-99.
25. 25. Tanabe K, Mackay M, Goman M, Scaife JG. (1987) Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 195: 273-287.
26. 26. McCutchan TF, Dame JB, Miller LH, Barnwell J. (1984) Evolutionary relatedness of Plasmodium species as determined by the structure of DNA. Science 225: 808-811.
27. 27. Kaslow DC, Hui G, Kumar S. (1994) Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSPI19) variants secreted from Saccharomyces cerevisiae. Mol. Biochem. Parasitol. 63: 283-294.
28. 28. Hommel U, Dudgeon TJ, Fallon A, Edwards RM, Campbell ID. (1991) Structure-function relationships in human epidermal growth factor studied by site-directed mutagenesis and 1H NMR. Biochemistry 30: 8891-8898.
29. 29. Kaslow DC, Bathurst IC, Lensen T, Ponnudurai T, Barr PJ, Keister DB. (1994) Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum. Infect. Immun. 62: 5576-5580.
30. 30. Engers HD, Godal T. (1998) Malaria vaccine development: current status. Parasitol. Today 14: 56-64.
31. 31. Mendis KN, Munasinghe YD, de Silva YNY, Keragala I, Carter R. (1987) Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans. Infect. Immun. 55: 369-372.
32. 32. Graves PM, Burkot TR, Carter R, et al. (1988) Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua New Guinea. Parasitology 96: 251-263.
33. 33. Graves PM, Burkol TR, Saul AJ, Hayes RJ. (1990) Estimation of anopheline survival rate, vectorial capacity and mosquito infection probability from malaria vector infection rates in villages near Madang, Papua New Guinea. J. Appl. Ecol. 27: 134-147.
34. 34. Gamage-Mendis AC, Rajakaruna J, Carter R, Mendis KN. (1991) Infectious reservoir of Plasmodium vivax and Plasmodium falciparum malaria in an endemic region of Sri Lanka. Am. J. Trop. Med. Hyg. 45: 479-487.
35. 35. Metselaar D. (1960) Relative increase in the prevalence of Plasmodium falciparum some years after the beginning of a house spraying campaign in Netherlands New Guinea. Trans. R. Soc. Trop. Med. Hyg. 54: 523-528.